Synthetic 20‐Epi Analogs of Calcitriol are Potent Inducers of Target‐Gene Activation in Osteoblastic Cells
- 1 May 1996
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 238 (1) , 97-103
- https://doi.org/10.1111/j.1432-1033.1996.0097q.x
Abstract
We have compared the actions of calcitriol and its three synthetic analogs, 20-epi-22-oxa-24a,26a,27a-trihomo-1 alpha,25-dihydroxyvitamin D3 (KH 1060), 1 alpha,24S-(OH)2-22-ene-26,27-cyclopropyl vitamin D3 (MC 903) and 20-epi-1 alpha,25-dihydroxyvitamin D3 (MC 1288), on the expression of two marker genes of differentiated osteoblasts, namely alkaline phosphatase and osteocalcin, using human MG-63 osteosarcoma cells. Calcitriol and the analogs had qualitatively similar stimulatory effects on target-gene activation. Quantitatively, MC 903 behaved in most experiments essentially as the parent compound calcitriol. In vitamin D receptor/DNA complex formation MC 903, however, was more potent than calcitriol. In contrast, the 20-epi analogs, KH 1060 and MC 1288, were much more potent even at lower concentrations, than calcitriol and MC 903 in stimulating alkaline phosphatase activity, osteocalcin mRNA synthesis and osteocalcin secretion. The stimulation occurred to a greater degree and for a longer period than with calcitriol. This effect was apparently mediated by stronger and longer lasting binding of the vitamin D receptor to the osteocalcin vitamin D responsive element by the 20-epi analogs. After a 6-h treatment and during subsequent culture without hormone, the effects of the 20-epi analogs were also stronger and lasted longer than those with calcitriol or MC 903. Collectively, at comparable and lower concentrations, the 20-epi analogs, KH 1060 and MC 1288, mediate much stronger and longer lasting stimulatory effects than calcitriol or its analog MC 903 on target-gene expression associated with the differentiated phenotype of the MG-63 human osteosarcoma cells.Keywords
This publication has 27 references indexed in Scilit:
- The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: Homodimers show higher ligand sensitivity than heterodimers with retinoid X receptorsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Functional Interference Between AP‐1 and the Vitamin D Receptor on Osteocalcin Gene Expression in Human Osteosarcoma CellsEuropean Journal of Biochemistry, 1994
- The expression of milligram amounts of functional human 1,25-dihydroxyvitamin D3 receptor in a bacterial expression systemBiochemical and Biophysical Research Communications, 1992
- Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potentialEndocrine Reviews, 1992
- Phenotype suppression: A postulated molecular mechanism for mediating the relationship of proliferation and differentiation by Fos/Jun interactions at AP‐1 sites in steroid responsive promoter elements of tissue‐specific genesJournal of Cellular Biochemistry, 1991
- Vitamin D: A modulator of cell proliferation and differentiationThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- The Role of Vitamin D in Bone and Intestinal Cell DifferentiationAnnual Review of Nutrition, 1990
- Comparative effects of a novel Vitamin D Analogue MC-903 and 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity, osteocalcin and DNA synthesis by human osteoblastic cells in cultureBone, 1990
- Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903)Archives of Dermatology, 1989
- 1,25-dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells)Biochemical and Biophysical Research Communications, 1980